Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention

Advanced Drug Delivery Reviews

Volumn 58, Issue 2, 2006, Pages 128-149

  Aigner, T ^a   Sachse, A ^b   Gebhard, P M ^a   Roach, H I ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cartilage; Cartilage regeneration; Chondrocytes; Drugs; Joints; Senescence

Indexed keywords

CARTILAGE; CELL CULTURE; ENZYME INHIBITION; JOINTS (ANATOMY); TISSUE;

CARTILAGE REGENERATION; CHONDROCYTES; SENESCENCE;

DISEASES;

AGGRECAN; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN FIBRIL; COLLAGEN TYPE 2; COLLAGENASE 3; MATRILYSIN; MATRIX METALLOPROTEINASE 14; NEUTROPHIL COLLAGENASE; OSTEOGENIC PROTEIN 1; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICULAR CARTILAGE; BONE PLATE; CARTILAGE CELL; CARTILAGE DEGENERATION; CARTILAGE MATRIX; CELL DEATH; CELL DEGENERATION; CELL PROLIFERATION; CHONDROGENESIS; DISEASE COURSE; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; INFLAMMATION; JOINT CAPSULE; JOINT FUNCTION; NONHUMAN; OSTEOARTHRITIS; OSTEOPHYTE; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STATISTICAL SIGNIFICANCE; SYNOVIAL FLUID; SYNOVIUM; TISSUE REPAIR;

ANTIRHEUMATIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; JOINT DISEASES; OSTEOARTHRITIS;

EID: 33646476551     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2006.01.020     Document Type: Review

References (169)

1. Dolan A.L., Hart D.J., Doyle D.V., Grahame R., and Spector T.D. The relationship of joint hypermobility, bone mineral density, and osteoarthritis in the general population: the Chingford study. J. Rheumatol. 30 (2003) 799-803
2. Heinegard D.K., and Pimentel E.R. Cartilage matrix proteins. In: Kuettner K., Schleyerbach R., Peyron J.G., and Hascall V.C. (Eds). Articular Cartilage and Osteoarthritis (1992), Raven Press, New York 95-110
3. Bruckner P., and van der Rest M. Structure and function of cartilage collagens. Microsc. Res. Technol. 28 (1994) 378-384
4. von der Mark K. Structure, biosynthesis and gene regulation of collagens in cartilage and bone. In: Seibel M.J., Robins S.P., and Bilezikian J.P. (Eds). Dynamics of Bone and Cartilage Metabolism (1999), Academic Press, San Diego 3-29
5. Mendler M., Eich-Bender S.G., Vaughan L., Winterhalter K.H., and Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX and XI. J. Cell Biol. 108 (1989) 191-197
6. Gelse K., Pöschl E., and Aigner T. Collagens-structure, function and biosynthesis. Adv. Drug Deliv. Rev. 55 (2003) 1531-1546
7. Wu J.-J., and Eyre D.R. Structural analysis of cross-linking domains in cartilage type XI collagen. J. Biol. Chem. 270 (1995) 18865-18870
8. van der Rest M., and Mayne R. Type IX collagen proteoglycan from cartilage is covalently cross-linked to type II collagen. J. Biol. Chem. 263 (1988) 1615-1618
9. Mayne R. Cartilage collagens-what is their function, and are they involved in articular disease?. Arthritis Rheum. 32-3 (1989) 241-246
10. Roughley P.J., and Lee E.R. Cartilage proteoglycans: structure and potential functions. Microsc. Res. Technol. 28 (1994) 385-397
11. Moore B.W. A soluble protein characteristic of the nervous system. Biochem. Biophys. Res. Commun. 19 (1965) 739-744
12. Carney S.L., and Muir H. The structure and function of cartilage proteoglycans. Physiol. Rev. 68 (1988) 858-910
13. Hedlund H., Mengeralli-Widholm S., Heinegard D.K., Reinholt F.P., and Svensson O. Fibromodulin distribution and association with collagen. Matrix Biol. 14 (1994) 227-232
14. Wiberg C., Hedbom E., Khairullina A., Lamande S.R., Oldberg A., Timpl R., Morgelin M., and Heinegard D. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J. Biol. Chem. 276 (2001) 18947-18952
15. Ayad S., Evans H., Weiss J.B., and Holt L. Type VI collagen but not type V collagen is present in cartilage. Collagen Relat. Res. 4 (1984) 165-168
16. Poole C.A., Ayad S., and Schofield J.R. Chondrons from articular cartilage: I. Immunolocalization of type VI collagen in the pericellular capsule of isolated canine tibial chondrons. J. Cell Sci. 90 (1988) 635-643
17. Poole C.A., Ayad S., and Gilbert R.T. Chondrons from articular cartilage: V. Immunohistochemical evaluation of type VI collagen organisation in isolated chondrons by light, confocal and electron microscopy. J. Cell Sci. 103 (1992) 1101-1110
18. Hambach L., Neureiter D., Zeiler G., Kirchner T., and Aigner T. Severe disturbance of the distribution and expression of type VI collagen chains in osteoarthritic articular cartilage. Arthritis Rheum. 41 (1998) 986-996
19. Söder S., Hambach L., Lissner R., Kirchner T., and Aigner T. Ultrastructural localization of type VI collagen in normal adult and osteoarthritic human articular cartilage. Osteoarthr. Cartil. 10 (2002) 464-470
20. Hardingham T.E., and Bayliss M.T. Proteoglycans of articular cartilage: changes in aging and in joint disease. Semin. Arthritis Rheum. 20-3 Suppl. 1 (1990) 12-33
21. Buckwalter J.A., Roughley P.J., and Rosenberg L.C. Age-related changes in cartilage proteoglycans: quantitative electron microscopic studies. Microsc. Res. Technol. 28 (1994) 398-408
22. Nguyen Q., Liu J., Roughley P.J., and Mort J.S. Link protein as a monitor in situ of endogenous proteolysis in adult human articular cartilage. Biochem. J. 278 (1991) 143-147
23. Hardingham T.E., and Fosang A.J. The structure of aggrecan and its turnover in cartilage. J. Rheumatol. 22 (1995) 86-90
24. Little C.B., Flannery C.R., Hughes C.E., Mort J.S., Roughley P.J., Dent C., and Caterson B. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro. Biochem. J. 344 Pt 1 (1999) 61-68
25. Aigner T., Hemmel M., Neureiter D., Gebhard P.M., Zeiler G., Kirchner T., and McKenna L.A. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritic human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 44 (2001) 1304-1312
26. Tortorella M.D., Pratta M., Liu R.Q., Austin J., Ross O.H., Abbaszade I., Burn T., and Arner E. Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4). J. Biol. Chem. 275 (2000) 18566-18573
27. Arner E.C., Pratta M.A., Decicco C.P., Xue C.B., Newton R.C., Trzaskos J.M., Magolda R.L., and Tortorella M.D. Aggrecanase. A target for the design of inhibitors of cartilage degradation. Ann. N.Y. Acad. Sci. 878 (1999) 92-107
28. Sandy J.D. Extracellular metabolism of aggrecan. In: Kuettner K., Schleyerbach R., Peyron J.G., and Hascall V.C. (Eds). Articular Cartilage and Osteoarthritis (1992), Raven Press, New York 21-33
29. Maroudas A., Bayliss M.T., Uchitel-Kaushansky N., Schneiderman R., and Gilav E. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. Arch. Biochem. Biophys. 350 (1998) 61-71
30. Bank R.A., Bayliss M.T., Lafeber F.P.J.G., Maroudas A., and TeKoppele J.M. Ageing and zonal variation in posttranslational modification of collagen in normal human articular cartilage. Biochem. J. 330 (1998) 345-351
31. Cawston T., Billington C., Cleaver C., Elliott S., Hui W., Koshy P., Shingleton B., and Rowan A. The regulation of MMPs and TIMPs in cartilage turnover. Ann. N.Y. Acad. Sci. 878 (1999) 120-129
32. Billinghurst R.C., Dahlberg L., Ionescu M., Reiner A., Bourne A., Rorabeck C., Mitchell P., Hambor J., Dieckmann O., Chen J., Van Wart H., and Poole A.R. Enhanced cleavage of type II collagen by collagenase in osteoarthritic articular cartilage. J. Clin. Invest. 99 (1997) 1534-1545
33. Lindblad S., and Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum. 30-10 (1987) 1081-1088
34. Oehler S., Neureiter D., Meyer-Scholten C., and Aigner T. Subtyping of osteoarthritic synoviopathy. Clin. Exp. Rheumatol. 20 (2002) 633-640
35. Ayral X., Pickering E.H., Woodworth T.G., Mackillop N., and Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis-results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthr. Cartil. 13 (2005) 361-367
36. Fassbender H.G. Inflammatory reactions in arthritis. In: Davies M.E., and Dingle J.T. (Eds). Immunopharmacology of Joints and Connective Tissue (1994), Academic Press, London 165-198
37. Dettmer N., and Barz B. Morphologische Veränderungen der synovialen Gelenkkapselanteile bei Arthrosis deformans. Arch. Orthop. Unfall-Chir. 89 (1977) 61-79
38. Hamerman D., and Klagsbrunn M. Osteoarthritis-emerging evidence for cell interactions in the breakdown and remodeling of cartilage. Am. J. Med. 78 (1985) 495-499
39. Gardner D.L. The nature and causes of osteoarthrosis. Br. Med. J. 286 (1983) 418-424
40. Graabek P.M. Characteristics of the two types of synoviocytes in rat synovial membrane: an ultrastructural study. Lab. Invest. 50 (1984) 690-702
41. Edwards J.C.W. The origin of type A synovial lining cells. Immunobiology 161 (1982) 227-231
42. Athanasou N.A., and Quinn J. Immunocytochemical analysis of human synovial lining dells: phenotypic relation to other marrow derived cells. Ann. Rheum. Dis. 50 (1991) 311-315
43. Walsh D.A., Sledge C.B., and Black D.R. Structure and function of joints, connective tissue and muscle. In: Kelly W.N., Shaun R., Harris E.D., and Sledge C.B. (Eds). Textbook of Rheumatology (1997), W.B. Saunders Company, Philadelphia 1-21
44. Revell P.A., Mayston V., Lalor P., and Mapp P. The synovial membrane in OA: a histologic study including the characterisation of the cellular infiltrate present in inflammatory OA using monoclonal antibodies. Ann. Rheum. Dis. 47 (1988) 300-307
45. Myers S.L., Flusser D., Brandt K.D., and Heck D.A. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis. J. Rheumatol. 19 (1992) 1247-1251
46. Goldenberg D.L., Egan M.S., and Cohen A.S. Inflammatory synovitis in degenerative joint disease. J. Rheumatol. 9 (1982) 204-209
47. Haraoui B., Pelletier J.P., Cloutier J.-M., Faure M.-P., and Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 34-2 (1991) 153-163
48. Smith M.D., Triantafillou S., Parker A., Youssef P.P., and Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J. Rheumatol. 24 (1997) 365-371
49. Firestein G.S., Paine M.M., and Littman B.H. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Arthritis Rheum. 34 (1991) 1094-1105
50. Gravallese E.M., Darling J.M., Ladd A.L., Katz J.N., and Glimcher L.H. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum. 34 (1991) 1076-1084
51. Tyler J.A. Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes decreased number of normal proteoglycan molecules. Biochem. J. 227 (1985) 869-878
52. Bau B., Gebhard P.M., Haag J., Knorr T., Bartnik E., and Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum. 46 (2002) 2648-2657
53. Lefebvre V., Peeters-Joris C., and Vaes G. Modulation by interleukin 1 and tumor necrosis factor a of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim. Biophys. Acta 1052 (1990) 366-378
54. Pihlajaniemi T., Myllylä R., Kukkinen M., and Prockop D.J. Partial characterization of a low molecular weight human collagen that undergoes alternative splicing. Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 940-944
55. Miossec P. Pro- and antiinflammatory cytokine balance in RA. Clin. Exp. Rheumatol. 13 (1995) 13-16
56. Lloyd-Roberts G.C. The role of capsular changes in osteoarthritis of the hip joint. J. Bone Jt. Surg. 35-B (1953) 627-642
57. Burr D.B. The importance of subchondral bone in osteoarthrosis. Curr. Opin. Rheumatol. 10 (1998) 256-262
58. Bergink A.P., Uitterlinden A.G., van Leeuwen J.P., Hofman A., Verhaar J.A., and Pols H.A. Bone mineral density and vertebral fracture history are associated with incident and progressive radiographic knee osteoarthritis in elderly men and women: the Rotterdam study. Bone 37 (2005) 446-456
59. Felson D.T., and Neogi T. Osteoarthritis: is it a disease of cartilage or of bone?. Arthritis Rheum. 50 (2004) 341-344
60. Amir G., Pirie C.J., Rashad S., and Revell P.A. Remodelling of subchondral bone in osteoarthritis: a histomorphometric study. J. Clin. Pathol. 45 (1992) 990-992
61. Dieppe P. Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis. Osteoarthr. Cartil. 7 (1999) 325-326
62. Felson D.T., Chaisson C.E., Hill C.L., Totterman S.M., Gale M.E., Skinner K.M., Kazis L., and Gale D.R. The association of bone marrow lesions with pain in knee osteoarthritis. Ann. Intern. Med. 134 (2001) 541-549
63. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., Rodan G.A., and Duong l.T. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum. 50 (2004) 1193-1206
64. Mankin H.J., Dorfman H., Lippiello L., and Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J. Bone Jt. Surg. 53-A (1971) 523-537
65. Mankin H.J., and Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J. Bone Jt. Surg. 52-A (1970) 424-434
66. Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 260 (1976) 808-809
67. Bank R.A., Krikken M., Beekman B., Stoop R., Maroudas A., Lafeber F.P.J.G., and Koppele J.M.T. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol. 16 (1997) 233-243
68. Dodge G.R., and Poole A.R. Immunohistochemical detection and immunohistochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J. Clin. Invest. 83 (1989) 647-661
69. Duerr S., Stremme S., Soeder S., Bau B., and Aigner T. MMP-2/gelatinase A is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage. Clin. Exp. Rheumatol. 22 (2004) 603-608
70. Aigner T., Zien A., Gehrsitz A., Gebhard P.M., and McKenna L.A. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum. 44 (2001) 2777-2789
71. Ohta S., Imai K., Yamashita K., Matsumoto T., Azumano I., and Okada Y. Expression of matrix metalloproteinase 7 (matrilysin) in human osteoarthritic cartilage. Lab. Invest. 78 (1998) 79-87
72. Shlopov B.V., Lie W.-R., Mainardi C.L., Cole A.A., Chubinskaya S., and Hasty K.A. Osteoarthritic lesions-involvement of three different collagenases. Arthritis Rheum. 40 (1997) 2065-2074
73. Chubinskaya S., Huch K., Mikecz K., Cs-Szabó G., Hasty K.A., Kuettner K.E., and Cole A.A. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 in human cartilage from knee and ankle joints. Lab. Invest. 74 (1996) 232-240
74. Freemont A.J., Hampson V., Tilman R., Goupille P., Taiwo Y., and Hoyland J.A. Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann. Rheum. Dis. 56 (1997) 542-549
75. S. Söder, H.I. Roach, S. Oehler, B. Bau, J. Haag, T. Aigner, MMP-9/gelatinase B is a gene product of human adult articular chondrocytes and increased in osteoarthritic cartilage, Clin. Exp. Rheumatol. (in press).
76. Mitchell P.G., Magna H.A., Reeves L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., Geoghegan K.F., and Hambor J.E. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J. Clin. Invest. 97 (1996) 761-768
77. Imai K., Ohta S., Matsumoto T., Fujimoto N., Sato H., Seiki M., and Okada Y. Expression of membrane-type 1 matrix metalloproteinase and activation of progelatinase A in human osteoarthritic cartilage. Am. J. Pathol. 151 (1997) 245-256
78. Lohmander L.S., Neame P.J., and Sandy J.D. The structure of aggrecan fragments in human synovial fluid-evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, and osteoarthritis. Arthritis Rheum. 36 (1993) 1214-1222
79. Malfait A.M., Liu R.Q., Ijiri K., Komiya S., and Tortorella M.D. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J. Biol. Chem. 277 (2002) 22201-22208
80. Chubinskaya S., Cs-Szabó G., and Kuettner K.E. ADAM-10 message is expressed in human articular cartilage. J. Histochem. Cytochem. 46 (1998) 723-729
81. Böhm B.B., Aigner T., Gehrsitz A., Blobel C.P., Kalden J.R., and Burkhardt H. Up-regulation of MDC15 (metargidin) mRNA in human osteoarthritic cartilage. Arthritis Rheum. 42 (1999) 1946-1950
82. Glasson S.S., Askew R., Sheppard B., Carito B., Blanchet T., Ma H.L., Flannery C.R., Peluso D., Kanki K., Yang Z., Majumdar M.K., and Morris E.A. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 434 (2005) 644-648
83. Stanton H., Rogerson F.M., East C.J., Golub S.B., Lawlor K.E., Meeker C.T., Little C.B., Last K., Farmer P.J., Campbell I.K., Fourie A.M., and Fosang A.J. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434 (2005) 648-652
84. Salter D.M. Tenascin is increased in cartilage and synovium from osteoarthritic knees. Br. J. Rheumatol. 32 (1993) 780-786
85. Aigner T., Zhu Y., Chanksy H., Matsen F.A., Maloney W.J., and Sandell L.J. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum. 42 (1999) 1443-1450
86. Aigner T., Bertling W., Stoss H., Weseloh G., and von der Mark K. Independent expression of fibril-forming collagens I, II, and III in chondrocytes of human osteoarthritic cartilage. J. Clin. Invest. 91 (1993) 829-837
87. Girkontaité I., Frischholz S., Lammi P., Wagner K., Swoboda B., Aigner T., and von der Mark K. Immunolocalization of type X collagen in normal fetal and adult osteoarthritic cartilage with monoclonal antibodies. Matrix Biol. 15 (1996) 231-238
88. Poole C.A., Matsuoka A., and Schofield J.R. Chondrons from articular cartilage: III. Morphologic changes in the cellular microenvironment of chondrons isolated from osteoarthritic cartilage. Arthritis Rheum. 34-1 (1991) 22-35
89. Swoboda B., Pullig O., Kirsch T., Klady B., Steinhäuser B., and Weseloh G. Increased content of type-VI collagen epitopes in human osteoarthritic cartilage: quantitation by inhibition ELISA. J. Orthop. Res. 16 (1998) 96-99
90. Ronzière M.-C., Ricard-Blum S., Tiollier J., Hartmann D.J., Garrone R., and Herbage D. Comparative analysis of collagens solubilized from human foetal, and normal and osteoarthritic adult articular cartilage, with emphasis on type VI collagen. Biochim. Biophys. Acta 1038 (1990) 222-230
91. McDevitt C.A., Pahl J.A., Ayad S., Miller R.R., Uratsuji M., and Andrish J.T. Experimental osteoarthritic articular cartilage is enriched in guanidine-soluble type VI collagen. Biochem. Biophys. Res. Commun. 157 (1988) 250-255
92. Marcelino J., and McDevitt C.A. Attachment of articular cartilage chondrocytes to the tissue form of type VI collagen. Biochim. Biophys. Acta 1249 (1995) 180-188
93. Loeser R.F. Growth factor regulation of chondrocyte integrins. Arthritis Rheum. 40 (1997) 270-276
94. Pfaff M., Aumailley M., Specks U., Knolle J., Zerwes H.G., and Timpl R. Integrin and Arg-Gly-Asp dependence of cell adhesion to the native and unfolded triple helix of collagen type VI. Exp. Cell Res. 206 (1993) 167-176
95. Lippiello L., Hall M.D., and Mankin H.J. Collagen synthesis in normal and osteoarthrotic human cartilage. J. Clin. Invest. 59 (1977) 593-600
96. Eyre D.R., McDevitt C.A., Billingham M.E.J., and Muir H. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem. J. 188 (1980) 823-837
97. Mankin H.J., Johnson M.E., and Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips: III. Distribution and metabolism of amino sugar-containing macromolecules. J. Bone Jt. Surg. 63-A-1 (1981) 131-139
98. Aigner T., Stoss H., Weseloh G., Zeiler G., and von der Mark K. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 62 (1992) 337-345
99. Aigner T., Vornehm S.I., Zeiler G., Dudhia J., von der Mark K., and Bayliss M.T. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum. 40 (1997) 562-569
100. Vornehm S.I., Dudhia J., von der Mark K., and Aigner T. Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol. 15 (1996) 91-98
101. Aigner T., Dietz U., Stoss H., and von der Mark K. Differential expression of collagen types I, II, III, and X in human osteophytes. Lab. Invest. 73 (1995) 236-243
102. Maroudas A. Physicochemical properties of articular cartilage. In: Freeman M.A.R. (Ed). Adult Articular Cartilage (1980), Pitman Medical Publishing, Tunbridge Wells 215-290
103. Lafeber F.P.J.G., van der Kraan P.M., van Roy J.L.A.M., van den Berg W.B., and Bijlsma J.W.J. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am. J. Pathol. 140 (1992) 1421-1429
104. Cancedda R., Descalzi-Cancedda F., and Castagnola P. Chondrocyte differentiation. Int. Rev. Cyt. 159 (1995) 265-358
105. Benya P.D., Padilla S.R., and Nimni M.E. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 15 (1978) 1313-1321
106. Benya P.D., Padilla S.R., and Nimni M.E. The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis. Biochemistry 16-5 (1977) 865-872
107. von der Mark K., Gauss V., von der Mark H., and Müller P.K. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 267 (1977) 531-532
108. Roach H.I., Yamada N., Cheung K.S.C., Tilley S., and Clarke N.M.P. Abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes is associated with demethylation of specific CpGs in the promotor. Arthritis Rheum. 52 (2005) 3110-3124
109. Roach H.I., Inglis S., Partridge K.A., Clarke N.M.P., and Richard O.C. Can Changes in the DNA Methylation Pattern Explain the Clonally Inherited Altered Phenotype of Osteoarthritic Chondrocytes?. In: Landis W., and Sodek J. (Eds) (2005), University of Toronto, Toronto
110. T. Aigner, P.M. Gebhard, S. Sesselmann, S. Söder, H.I. Roach, DNA methylation, chondrogenesis, and cartilage degeneration, Curr. Rheumatol. (in press).
111. Reboul P., Pelletier J.P., Tardif G., Benderdour M., Ranger P., Bottaro D.P., and Martel-Pelletier J. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage. Arthritis Rheum. 44 (2001) 73-84
112. Bau B., McKenna L.A., Soeder S., Fan Z., Pecht A., and Aigner T. Hepatocyte growth factor/scatter factor is not a potent regulator of anabolic and catabolic gene expression in adult human articular chondrocytes. Biochem. Biophys. Res. Commun. 316 (2004) 984-990
113. Shuler F.D., Georgescu H.I., Niyibizi C., Studer R.K., Mi Z., Johnstone B., Robbins R.D., and Evans C.H. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J. Orthop. Res. 18 (2000) 585-592
114. Chubinskaya S., Merrihew C., Cs-Szabó G., Mollenhauer J., McCartney J., Rueger D.C., and Kuettner K.E. Human articular chondrocytes express osteogenic protein-1. J. Histochem. Cytochem. 48 (2000) 239-250
115. Fukui N., Zhu Y., Maloney W.J., Clohisy J., and Sandell L.J. Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J. Bone Jt. Surg., Am. 85-A Suppl. 3 (2003) 59-66
116. Flechtenmacher J., Huch K., Thonar E.J.M.A., Mollenhauer J., Davies S.R., Schmid T., Puhl W., Sampath T.K., Aydelotte M.B., and Kuettner K.E. Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum. 39 (1996) 1896-1904
117. Fan Z., Chubinskaya S., Rueger D., Bau B., Haag J., and Aigner T. Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin. Exp. Rheumatol. 22 (2004) 103-106
118. Tyler J.A. Insulin-like growth factor I can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem. J. 260 (1989) 543-548
119. Goldring M.B. Anticytokine therapy for osteoarthritis. Expert Opin. Biol. Ther. 1 (2001) 817-829
120. Fernandes J.C., Martel-Pelletier J., and Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39 (2002) 237-246
121. Fan Z., Bau B., Yang H., Soeder S., and Aigner T. Freshly isolated osteoarthritic chondrocytes are catabolic more active than normal chondrocytes, but less responsive to catabolic stimulation with IL-1β. Arthritis Rheum. 52 (2005) 136-143
122. Fan Z., Bau B., Yang H., and Aigner T. IL-beta induction of IL-6 and LIF in normal articular human chondrocytes involves the ERK, p38 and NFkB signaling pathways. Cytokine 28 (2004) 17-24
123. Henrotin Y., Kurz B., and Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthr. Cartil. 13 (2005) 643-654
124. Y. Henrotin, Antioxidant to treat osteoarthritis: dream or reality? Curr. Drug Targets (in press).
125. Amin A.R., Dave M., Attur M., and Abramson S.B. COX-2, NO, and cartilage damage and repair. Curr. Rheumatol. Rep. 2 (2000) 447-453
126. Rothwell A.G., and Bentley G. Chondrocyte multiplication in osteoarthritic articular cartilage. J. Bone Jt. Surg. 55-B (1973) 588-594
127. Hulth A., Lindberg L., and Telhag H. Mitosis in human articular osteoarthritic cartilage. Clin. Orthop. 84 (1972) 197-199
128. Aigner T., and Kim A.H. Apoptosis and cellular vitality-issues in osteoarthritic cartilage degeneration. Arthritis Rheum. 46 (2002) 1986-1996
129. Aigner T., Kim H.A., and Roach H.I. Apoptosis in osteoarthritis. Rheum. Dis. Clin. North Am. 30 (2004) 639-653
130. Blanco F.J., Guttian R., Vázquez-Martul E., de Toro F.J., and Galdo F. Osteoarthritic chondrocytes die by apoptosis. Arthritis Rheum. 41 (1998) 284-289
131. Hashimoto S., Ochs R.L., Komiya S., and Lotz M. Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum. 41 (1998) 1632-1638
132. Heraud F., Heraud A., and Harmand M.F. Apoptosis in normal and osteoarthritic human articular cartilage. Ann. Rheum. Dis. 59 (2000) 959-965
133. Roach H.I., Aigner T., and Kouri J.B. Chondroptosis: a variant of apoptotic cell death in chondrocytes?. Apoptosis 9 (2004) 265-278
134. Vignon E., Arlot M., Patricot L.M., and Vignon G. The cell density of human femoral head cartilage. Clin. Orthop. 121 (1976) 303-308
135. Bullough P.G. The pathology of osteoarthritis. In: Moskowitz R.W., Howell D.S., Goldberg V.M., and Mankin H.J. (Eds). Osteoarthritis (1992), Saunders, Philadelphia 39-69
136. Resnick D. Osteophytosis of the femoral head and neck. Arthritis Rheum. 26-7 (1983) 908-913
137. Jeffery A.K. Osteophytes and the osteoarthritic femoral head. J. Bone Jt. Surg. 57-B (1975) 314-324
138. Milgram J.W. Morphologic alterations of the subchondral bone in advanced degenerative arthritis. J. Orthop. Relat. Res. 173 (1983) 293-312
139. Gelse K., Soeder S., Eger W., Diemtar T., and Aigner T. Osteophyte development-molecular characterization of differentiation stages. Osteoarthr. Cartil. 11 (2003) 141-148
140. Reichenberger E., Aigner T., von der Mark K., Stöss H., and Bertling W. In situ hybridization studies on the expression of type X collagen in fetal human cartilage. Dev. Biol. 148 (1991) 562-572
141. Gelse K., Jiang Q.J., Aigner T., Ritter T., Wagner K., Poschl E., von der Mark K., and Schneider H. Fibroblast-mediated delivery of growth factor complementary DNA into mouse joints induces chondrogenesis but avoids the disadvantages of direct viral gene transfer. Arthritis Rheum. 44 (2001) 1943-1953
142. Van Beuningen H.M., Glansbeek H.L., van der Kraan P., and van den Berg W.B. Differential effects of local application of BMP-2 or TGF-β on both articular cartilage composition and osteophyte formation. Osteoarthr. Cartil. 6 (1998) 306-317
143. Hunziker E.B., Driesang I.M., and Morris E.A. Chondrogenesis in cartilage repair is induced by members of the transforming growth factor-beta superfamily. Clin. Orthop. (2001) S171-S181
144. Hiraki Y., Inoue H., Shigeno C., Sanma C., Bentz H., Roen D.M., Asada A., and Suzuki F. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro. J. Bone Miner. Res. 6 (1991) 1373-1385
145. Sandell L.J., and Adler P. Developmental patterns of cartilage. Front. Biosci. 4 (1999) D731-D742
146. Uchino M., Izumi T., Tominaga T., Wakita R., Minehara H., Sekiguchi M., and Itoman M. Growth factor expression in the osteophytes of the human femoral head in osteoarthritis. Clin. Orthop. 377 (2000) 119-125
147. Okazaki K., Jingushi S., Ikenoue T., Urabe K., Sakai H., Ohtsuru A., Akino K., Yamashita S., Nomura S., and Iwamoto Y. Expression of insulin-like growth factor I messenger ribonucleic acid in developing osteophytes in murine experimental osteoarthritis and in rats inoculated with growth hormone-secreting tumor. Endocrinology 140 (1999) 4821-4830
148. Dodds R.A., Merry K., Littlewood A., and Gowen M. Expression of mRNA for IL-1b, IL-6 and TGF-b in developing human bone and cartilage. J. Histochem. Cytochem. 42 (1994) 733-744
149. Dodds R.A., Merry K., Littlewood A., and Gowen M. A method for the localization of cytokine mRNA expression in adult human bone by in situ hybridization. Bone 14 (1993) 305-307
150. Mainil-Varlet P. Cartilage tissue engineering for degenerate joint disease. Adv. Drug Deliv. Rev. 58 (2006) 300-322 10.1016/j.addr.2006.01.012 (this issue)
151. Mainil-Varlet P., Aigner T., Brittberg M., Bullough P., Hollander A., Hunziker E., Kandel R., Nehrer S., Pritzker K., Roberts S., and Stauffer E. Histological assessment of cartilage repair: a report by the histology endpoint committee of the International Cartilage Repair Society (ICRS). J. Bone Jt. Surg., Am. 85-A Suppl. 2 (2003) 45-57
152. Buckwalter J.A., and Mow V.C. Cartilage repair in osteoarthritis. In: Moskowitz R.W., Howell D.S., Goldberg V.M., and Mankin H.J. (Eds). Osteoarthritis (1992), Saunders, Philadelphia 71-107
153. Sellers R.S., Peluso D., and Morris E.A. The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage. J. Bone Jt. Surg. 79-A (1997) 1452-1463
154. Shapiro F., Koide S., and Glimcher M.J. Cell origin and differentiation in the repair of full-thickness defects of articular cartilage. J. Bone Jt. Surg. 75-A (1993) 532-553
155. Nehrer S., Spector M., and Minas T. Histologic analysis of tissue after failed cartilage repair procedures. Clin. Orthop. (1999) 149-162
156. Roberts S., Hollander A.P., Caterson B., Menage J., and Richardson J.B. Matrix turnover in human cartilage repair tissue in autologous chondrocyte implantation. Arthritis Rheum. 44 (2001) 2586-2598
157. Brittberg M., Nilsson A., Lindahl A., Ohlsson C., and Peterson L. Rabbit articular cartilage defects treated with autologous cultured chondrocytes. Clin. Orthop. 326 (1996) 270-283
158. Breinan H.A., Minas T., Hsu H.P., Nehrer S., Shortkroff S., and Spector M. Autologous chondrocyte implantation in a canine model: change in composition of reparative tissue with time. J. Orthop. Res. 19 (2001) 482-492
159. Mainil-Varlet P., Rieser F., Grogan S., Mueller W., Saager C., and Jakob R.P. Articular cartilage repair using a tissue-engineered cartilage-like implant: an animal study. Osteoarthr. Cartil. 9 Suppl. A (2001) S6-S15
160. Rahfoth B., Weisser J., Sternkopf F., Aigner T., and von der Mark K. Transplantation of allograft chondrocytes embedded in agarose gel into cartilage defects of rabbits. Osteoarthr. Cartil. 6 (1998) 50-65
161. Whipple R.R., Gibbs M.C., and Lai W.M. Biphasic properties of repaired cartilage at the articular surface. Trans. Orthop. Res. Soc. 10 (1985) 340
162. Campell C.J. The healing of cartilage defects. Clin. Orthop. 64 (1969) 45-63
163. DePalma A.F., McKeever C.D., and Subin D.K. Process of repair of articular cartilage demonstrated by histology and autoradiography with tritiated thymidine. Clin. Orthop. 48 (1966) 229-242
164. von der Mark K. Differentiation, modulation and dedifferentiation of chondrocytes. Rheumatology 10 (1986) 272-315
165. Aigner T., and Dudhia J. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann. Rheum. Dis. 56 (1997) 287-291
166. Valdes A.M., Hart D.J., Jones K.A., Surdulescu G., Swarbrick P., Doyle D.V., Schafer A.J., and Spector T.D. Association study of candidate genes for the prevalence and progression of knee osteoarthritis. Arthritis Rheum. 50 (2004) 2497-2507
167. Loughlin J. The genetic epidemiology of human primary osteoarthritis: current status. Expert Rev. Mol. Med. 7 (2005) 1-12
168. Aigner T., Zien A., Bartnik E., and Zimmer R. Functional genomics of osteoarthritis. Pharmacogenomics 3 (2002) 635-650
169. Aigner T., Bartnik E., Sohler F., and Zimmer R. Functional genomics of osteoarthritis: on the way to evaluate disease hypotheses. Clin. Orthop. 1 (2004) S138-S143